In addition, a study reported that the S100B protein could reduce tumor suppressor p53 DNA binding and transcriptional activity, and meanwhile indicated that since S100B levels are significantly elevated in glioma and astrocytoma, it may contribute to glioma and astrocytoma progression by inhibiting p53 functions 92. Here, TP53 is linked to central nervous system cancer.